GLOBAL HEALTH
Prostate cancer is the most common cancer among men and the leading cause of cancer death among men in Africa. The number of years of life lost (YLL) due to prostate cancer has been on the increase over the last two decades and it is also projected to double in Africa by the year 2040. It is estimated that about 15 men die of prostate cancer every day in Nigeria.
Prostate cancer is the most common cancer among men and the leading cause of cancer death among men in Africa. The number of years of life lost (YLL) due to prostate cancer has been on the increase over the last two decades and it is also projected to double in Africa by the year 2040. It is estimated that about 15 men die of prostate cancer every day in Nigeria.
What are the Key Statistics About Prostate Cancer?
Race and ethnicity:
Prostate cancer is more common and causes more deaths in Black men than in their White counterparts. Our research group has found that Black people have a nature that is more ‘inflammatory’ within.
Early Detection:
It is possible to detect cancer before it starts showing symptoms. The Digital rectal exam (DRE) and Prostate Specific Antigen (PSA) test are two simple tests that can help to identify abnormalities in the prostate. However, they cannot show whether the anomalies are due to cancer or not.
Meet Our Consortium MPI's
Meet Our Consortium MPI's
Dr. Ernie Kaninjing
GEORGIA COLLEGE
Dr. Kaninjing, a behavioral scientist with prostate cancer and health disparity research expertise.
Dr. Solomon Rotimi
COVENANT UNIVERSITY
Dr. Rotimi is a Professor at Covenant University, Nigeria with a broad background in Clinical Biochemistry.
Prostate Cancer Survivors Share Their Stories
Listen, as numerous prostate cancer survivors speak on their experience upon hearing their diagnosis, survivorship, the importance of advocacy and speaking up on getting tested for prostate cancer within the African American community.
Prostate Cancer Survivors Share Their Stories
ECANCER VIDEO
iCCaRE Addressing the disproportionate burden of prostate cancer in black men
iCCaRE Addressing
the disproportionate
burden of prostate
cancer
Mr Arnold Merriweather (Prostate Cancer Survivor and Community Advocate, MPI, Florida, USA), Dr Che Ngufor (MPI, Mayo Clinic, Rochester, USA) and Dr Folakemi Odedina (MPI, Mayo Clinic, Florida, USA) introduce iCCaRE and discuss it’s purpose.
Meet Our Partners
Meet Our Partners
